Literature DB >> 19039210

Chronic kidney disease and US healthcare resource utilization in a nationally representative sample.

Marcus Alexander1, Brian D Bradbury, Reshma Kewalramani, Arie Barlev, Sarita A Mohanty, Denise Globe.   

Abstract

BACKGROUND: Chronic kidney disease (CKD) is a prevalent condition; however, little is known about healthcare resource utilization (HRU) by CKD patients.
METHODS: This analysis included NHANES participants aged > or =18 years, with serum creatinine, urine protein, and hemoglobin measurements. We assessed the association between CKD (stratified by stage) and HRU based on self-reported physician visits and hospitalizations in the year preceding the survey.
RESULTS: Of the 15,258 included in this analysis, 2,110 had early CKD (stage 1 and 2 CKD) and 1,121 had late CKD (stage 3 and 4 CKD). Mean (SE) number of annual physician visits were 3.51 (0.08), 4.43 (0.18), and 6.53 (0.38) for participants with no CKD, early CKD, and late CKD, respectively. Mean (SE) number of annual hospitalizations were 0.15 (0.01), 0.19 (0.01), and 0.42 (0.03) for participants with no CKD, early CKD, and late CKD, respectively. Participants with late CKD were more likely to have more physician visits (OR 1.81, 95% CI 1.46, 2.23) and have more hospital admissions (OR 2.12, 95% CI 1.66, 2.71) compared with participants with early CKD or no CKD.
CONCLUSIONS: In this analysis, late stage CKD was associated with increased HRU, suggesting the need for early identification and treatment of CKD and its associated conditions. Copyright (c) 2008 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2008        PMID: 19039210     DOI: 10.1159/000178816

Source DB:  PubMed          Journal:  Am J Nephrol        ISSN: 0250-8095            Impact factor:   3.754


  6 in total

1.  Access to health care among adults evaluated for CKD: findings from the Kidney Early Evaluation Program (KEEP).

Authors:  Varun Agrawal; Bernard G Jaar; Xenia Y Frisby; Shu-Cheng Chen; Yang Qiu; Suying Li; Adam T Whaley-Connell; Peter A McCullough; Andrew S Bomback
Journal:  Am J Kidney Dis       Date:  2012-03       Impact factor: 8.860

2.  High burden and unmet patient needs in chronic kidney disease.

Authors:  Leeann Braun; Vipan Sood; Susan Hogue; Bonnie Lieberman; Catherine Copley-Merriman
Journal:  Int J Nephrol Renovasc Dis       Date:  2012-12-13

3.  Incremental health care resource utilization and expenditures associated with autosomal-dominant polycystic kidney disease.

Authors:  Neeraj N Iyer; Nicholas J Vendetti; Daniel I Levy; Jack Mardekian; Marko A Mychaskiw; Joseph Thomas
Journal:  Clinicoecon Outcomes Res       Date:  2018-10-31

4.  Hospitalizations among adults with chronic kidney disease in the United States: A cohort study.

Authors:  Sarah J Schrauben; Hsiang-Yu Chen; Eugene Lin; Christopher Jepson; Wei Yang; Julia J Scialla; Michael J Fischer; James P Lash; Jeffrey C Fink; L Lee Hamm; Radhika Kanthety; Mahboob Rahman; Harold I Feldman; Amanda H Anderson
Journal:  PLoS Med       Date:  2020-12-11       Impact factor: 11.069

5.  Effect of Levothyroxine on Kidney Function in Chronic Kidney Disease with Subclinical Hypothyroidism in US Veterans: A Retrospective Observational Cohort Study.

Authors:  James V Hennessey; Matthew R Weir; Seema Soni-Brahmbhatt; Yinghui Duan; Ved V Gossain
Journal:  Adv Ther       Date:  2020-12-23       Impact factor: 3.845

6.  Cost of End-of-Life Inpatient Encounters in Patients with Chronic Kidney Disease in the United States: A Report from the DISCOVER CKD Retrospective Cohort.

Authors:  Carol Pollock; Glen James; Juan Jose Garcia Sanchez; Matthew Arnold; Juan-Jesus Carrero; Carolyn S P Lam; Hungta Chen; Stephen Nolan; Roberto Pecoits-Filho
Journal:  Adv Ther       Date:  2022-02-03       Impact factor: 3.845

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.